rs6656559
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005401.5(PTPN14):c.175-1266A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 152,198 control chromosomes in the GnomAD database, including 6,845 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6845 hom., cov: 33)
Consequence
PTPN14
NM_005401.5 intron
NM_005401.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.22
Publications
3 publications found
Genes affected
PTPN14 (HGNC:9647): (protein tyrosine phosphatase non-receptor type 14) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]
PTPN14 Gene-Disease associations (from GenCC):
- lymphedema-posterior choanal atresia syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.359 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTPN14 | NM_005401.5 | c.175-1266A>T | intron_variant | Intron 2 of 18 | ENST00000366956.10 | NP_005392.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.277 AC: 42173AN: 152080Hom.: 6844 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
42173
AN:
152080
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.277 AC: 42179AN: 152198Hom.: 6845 Cov.: 33 AF XY: 0.279 AC XY: 20725AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
42179
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
20725
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
4797
AN:
41564
American (AMR)
AF:
AC:
4538
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
716
AN:
3470
East Asian (EAS)
AF:
AC:
815
AN:
5186
South Asian (SAS)
AF:
AC:
1126
AN:
4824
European-Finnish (FIN)
AF:
AC:
4414
AN:
10568
Middle Eastern (MID)
AF:
AC:
82
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24688
AN:
67992
Other (OTH)
AF:
AC:
587
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1482
2964
4447
5929
7411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
838
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.